Scaglione v. CIGNA HealthCare of St. Louis, Inc.

242 F. Supp. 2d 629, 29 Employee Benefits Cas. (BNA) 2823, 2002 U.S. Dist. LEXIS 25474, 2002 WL 31957434
CourtDistrict Court, E.D. Missouri
DecidedDecember 22, 2002
Docket4:00-cv-01674
StatusPublished

This text of 242 F. Supp. 2d 629 (Scaglione v. CIGNA HealthCare of St. Louis, Inc.) is published on Counsel Stack Legal Research, covering District Court, E.D. Missouri primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Scaglione v. CIGNA HealthCare of St. Louis, Inc., 242 F. Supp. 2d 629, 29 Employee Benefits Cas. (BNA) 2823, 2002 U.S. Dist. LEXIS 25474, 2002 WL 31957434 (E.D. Mo. 2002).

Opinion

242 F.Supp.2d 629 (2002)

Dominic SCAGLIONE, Plaintiff,
v.
CIGNA HEALTHCARE OF ST. LOUIS, INC., et al., Defendant.

No. 4:00-CV-01674HEA.

United States District Court, E.D. Missouri, Eastern Division.

December 22, 2002.

*630 Mitchell D. Jacobs, Clayton, MO, for plaintiff.

*631 Terese A. Drew, Hinshaw and Culbertson, Kathleen R. Richards, Sandberg and Phoenix, Brent W. Baldwin, Lathrop and Gage, St. Louis, MO, Daniel K. Ryan, Hinshaw and Culbertson, Chicago, IL, Dennie M. Zankel, Williams and Venker, St. Louis, MO, for defendant.

FINDINGS OF FACT AND CONCLUSIONS OF LAW

AUTREY, District Judge.

This matter is before the Court upon Complaint by Plaintiff alleging that Plaintiff, an employee of BetzDearborn, Inc., was a covered employee under a Health benefit plan which was administered by defendant.[1] Plaintiff further alleges that the benefit plan is one which is governed by the Employee Income Security Act of 1974 (ERISA), 29 U.S.C. § 1001 et seq. Jurisdiction is conferred upon the Court pursuant to a Notice of Removal under 28 U.S.C. § 1441(b) and federal question jurisdiction under 28 U.S.C. § 1331 AND 29 U.S.C. § 1001 et seq.

On November 5, 2001 the parties agreed to submit briefs on the salient issues and facts in lieu of trial. Subsequent thereto, and after a number of extensions of time to file the briefs, Plaintiff filed its trial brief (# 54) on May 10, 2002. Defendant also filed its "Brief In Support Of Judgment in Its Favor And Against Plaintiff (# 55) on May 10, 2002. Both were filed contemporaneously with a "Joint Stipulations Of Fact"(# 56). The Plaintiff filed a "Reply to Defendant's Trial Brief (# 73) on May 30, 2002. The Defendant then filed it's "Response To Plaintiffs Reply To Defendant's Trial Brief (# 75) on June 7, 2002. On October 3, 2002 this matter was transferred from the Honorable Donald J. Stohr to the undersigned.

BACKGROUND[2]

Dominic Scaglione was an employee of BetzDearborn, Inc. His employer provided an employee health benefit plan (the "Plan") which was administered by the Defendant as claims administrator with respect to medical benefits. The medical benefits under the Plan were selffunded by the employer(Exh. D, ¶ 2).

During the relevant time period Plaintiff sought medical treatment for a back ailment. As required by the Plan, Mr. Scaglione received authorization from the Plan administrator to undergo back surgery. Rather than proceed with the more invasive back surgery, Plaintiff sought approval from defendant for a procedure known as the Vertebral Axial Decompression program("VAX-D"). This is a mechanical traction procedure[3] that is less expensive than surgery.

The Plan granted the Defendant discretion to determine eligibility for benefits under the Plan. Upon review of the Plaintiffs request for payment for the VAX-D treatment the request was denied on the ground that the VAX-D treatment was "unproven technology". Mr. Scaglione properly appealed the denial and Defendant denied the appeal, finding that "coverage for the VAX-D treatment has been denied due to no long-term studies showing efficacy". The Plaintiff appealed this *632 decision and payment was again denied. The Defendant concluded that:

The benefits that CIGNA HealthCare of St. Louis, Inc. administers on behalf of your employer, BetzDearborn, indicate that `No payment will be made under the CIGNA medical plans for the expenses incurred for you or your covered dependents:
For or in connection with experimental procedures or treatment methods not approved by the American Medical Association or the appropriate medical specialty society'. (The Plan, page 3-27)

Even though his requests for approval had been denied, the Plaintiff went forward with the VAX-D treatments and program. Prior to the treatment, however, he treated with Dr. Jonathan Gold. Dr. Gold performed certain diagnostic tests which included an MRI on November 1, 1999 and a Myelogram. These tests were indicative of a herniated nucleus pulposis at two different disk levels. As a result of these findings Mr. Scaglione was scheduled for emergency surgery on November 23, 1999. Plaintiff did not undergo the surgery, but rather treated with Dr. Ferris who provided VAX-D treatment for Plaintiff. Upon examination of Mr. Scaglione, Dr. Ferris diagnosed him as suffering from degenerative disc disease with L4-5 herniation and L5-S1 posterior facet syndrome.

Defendant made certain payments to Dr. Ferris for the treatment of Mr. Scaglione in relation to the VAX-D treatment. There have been payments in other instances totalling $36,092. The Defendant made demand to Dr. Ferris for the return of the payments for the VAX-D treatments and procedures. The aggregate cost of treatment to the Plaintiff is $2880.00.

Prior to Plaintiffs request for payment of his claim for VAX-D treatment the Defendant had paid for treatment on six other claims and has paid for treatment on eight claims after the denial of Plaintiffs request. [Deposition of Angela Moses, page 6, line 19 through page 7 line 10 and page 8, lines 12-23]. In addition, the record discloses that on December 14, 1999, the Defendant paid $108 toward treatment provided to Plaintiff by Dr. Ferris. Explanation of Benefits [Joint Docs, document number 7].

DISCUSSION

A. Standard of Review

Actions, such as this, brought pursuant to 29 U.S.C. § 1001 et seq (ERISA) are granted judicial review of medical benefit denial decisions. The general view is that the district court reviewing a denial of benefits should use a de novo standard of review. Milone v. Exclusive Healthcare, Inc., 244 F.3d 615 (8th Cir.2001).[4] The Supreme Court has recognized, however, that a deferential standard of review is appropriate under 29 U.S.C. § 1132(a)(1)(B). Firestone Tire & Rubber Co. v. Bruch, 489 U.S. 101, 115, 109 S.Ct. 948, 103 L.Ed.2d 80 (1989). The deferential standard of review must be applied if "the benefit plan gives the administrator or fiduciary discretionary authority to determine eligibility for benefits or to construe the terms of the plan." Firestone Tire & Rubber Co., at 115, 109 S.Ct. 948. If discretionary authority is granted to the plan administrator, it is incumbent upon the reviewing court to review the plan administrator's decision for abuse of discretion. See id. at 898. Here, the parties have agreed, through their Joint Stipulations of Fact that defendant, the Plan administrator, *633 had discretion to determine eligibility for benefits. Thus, the deferential standard of review is utilized in assessing the validity of the decision of the Plan administrator herein.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
242 F. Supp. 2d 629, 29 Employee Benefits Cas. (BNA) 2823, 2002 U.S. Dist. LEXIS 25474, 2002 WL 31957434, Counsel Stack Legal Research, https://law.counselstack.com/opinion/scaglione-v-cigna-healthcare-of-st-louis-inc-moed-2002.